Irritable Bowel Syndrome Stocks List

Irritable Bowel Syndrome Stocks Recent News

Date Stock Title
May 9 BHC Salix Pharmaceuticals announces Bellamy Young as Spokesperson for Xifaxan(R) (rifaximin)
May 9 ABBV Q1 2024 Regenxbio Inc Earnings Call
May 8 IRWD Ironwood Pharmaceuticals Q1 2024 Earnings Preview
May 8 ABBV QULIPTA™ (atogepant) Now Approved by Health Canada for the Preventive Treatment of Chronic Migraine in Adults
May 8 ABT Got $1,000? 3 Dividend Stocks to Buy and Hold Forever
May 8 ABT The Zacks Analyst Blog Highlights Tesla, Johnson & Johnson, Netflix, Abbott and ConocoPhillips
May 7 ABBV Teva Earnings Are Soon. What Could Keep the Stock Gains Going.
May 7 ABBV 15 Best S&P 500 Dividend Stocks To Buy Now
May 7 ABT 13 Best Stocks That Will Always Grow
May 7 BHC Why Bausch Health Stock Plunged After Posting First Quarter 2024 Results
May 7 ARDX Ardelyx to Present Additional Data Supporting First-In-Class IBSRELA® (tenapanor) for Adults with Irritable Bowel Syndrome with Constipation at the 2024 Digestive Disease Week Conference
May 6 ARDX (ARDX) - Analyzing Ardelyx's Short Interest
May 6 IRWD Ironwood Pharmaceuticals to Participate in The Citizens JMP Life Sciences Conference
May 6 ABT 11 Best Recession Dividend Stocks To Buy
May 6 LXRX Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) Q1 2024 Earnings Call Transcript
May 6 ABBV 10 Best May Dividend Stocks To Buy
May 6 ABBV AbbVie to Present at the Bank of America Securities Healthcare Conference
May 6 BHC Bausch Health Companies (NYSE:BHC investor three-year losses grow to 72% as the stock sheds US$388m this past week
May 5 ABBV 3 Reasons to Buy AbbVie Stock on the Dip
May 5 LXRX Lexicon Pharmaceuticals, Inc. (LXRX) Q1 2024 Earnings Call Transcript
Irritable Bowel Syndrome

Irritable bowel syndrome (IBS) is a group of symptoms—including abdominal pain and changes in the pattern of bowel movements without any evidence of underlying damage. These symptoms occur over a long time, often years. It has been classified into four main types depending on whether diarrhea is common, constipation is common, both are common, or neither occurs very often (IBS-D, IBS-C, IBS-M, or IBS-U respectively). IBS negatively affects quality of life and may result in missed school or work. Disorders such as anxiety, major depression, and chronic fatigue syndrome are common among people with IBS.The causes of IBS are not clear. Theories include combinations of gut–brain axis problems, gut motility disorders, pain sensitivity, infections including small intestinal bacterial overgrowth, neurotransmitters, genetic factors, and food sensitivity. Onset may be triggered by an intestinal infection, or stressful life event. IBS is a functional gastrointestinal disorder. Diagnosis is based on signs and symptoms in the absence of worrisome features. Worrisome features include onset at greater than 50 years of age, weight loss, blood in the stool, or a family history of inflammatory bowel disease. Other conditions that may present similarly include celiac disease, microscopic colitis, inflammatory bowel disease, bile acid malabsorption, and colon cancer.There is no known cure for IBS. Treatment is carried out to improve symptoms. This may include dietary changes, medication, probiotics, and counseling. Dietary measures include increasing soluble fiber intake, a gluten-free diet, or a short-term diet low in fermentable oligosaccharides, disaccharides, monosaccharides, and polyols (FODMAPs). The medication loperamide may be used to help with diarrhea while laxatives may be used to help with constipation. Antidepressants may improve overall symptoms and pain. Patient education and a good doctor–patient relationship are an important part of care.About 10 to 15% of people in the developed world are believed to be affected by IBS. It is more common in South America and less common in Southeast Asia. It is twice as common in women as men and typically occurs before age 45. The condition appears to become less common with age. IBS does not affect life expectancy or lead to other serious diseases. The first description of the condition was in 1820 while the current term "irritable bowel syndrome" came into use in 1944.

Browse All Tags